McDonald’s, the iconic fast food giant with golden arches recognized around the world, is quietly preparing for a seismic shift in how people eat. On February 18, 2026, executives revealed during an earnings call that the rise of GLP-1 weight-loss drugs—think Ozempic, Wegovy, and Mounjaro—is already changing what customers order, how much they eat, and even what they crave. The company is now testing new menu strategies to keep pace with these evolving habits, and the stakes couldn’t be higher for both diners and investors.
So, what’s really happening? According to Simply Wall St and other sources, a growing number of consumers are using GLP-1 analog medications, which are known to suppress appetite and shift food preferences. That means fewer sugary drinks, fewer snacks, and a surge of interest in protein-rich foods. McDonald’s CEO Chris Kempczinski put it plainly on the call: “When adoption increases, the way we consume also changes.” This shift, he explained, is forcing the company to rethink its menu, but without alienating its loyal, traditional customers.
McDonald’s is already testing adjustments—though it hasn’t announced a formal list of new menu items yet. Instead, the company is focusing on what it already does well, like offering protein-forward options. Vice President Jill McDonald pointed out that existing items such as the Snack Wrap, sausage and biscuit sandwich, and McCrispy chicken strips could become the stars of the menu. “We already have items perceived as higher in protein,” she said, hinting at a possible repositioning of these products to appeal to health-conscious, GLP-1-using customers.
This isn’t just a matter of swapping out fries for grilled chicken. The change is showing up everywhere: at the counter, on the app, in the drive-thru, and in the subtle ways people build their orders. As Simply Wall St noted, McDonald’s is also expanding its beverage and chicken offerings while planning to open about 2,600 new restaurants in 2026. The company’s stock price, trading around $327.62 as of mid-February, has seen a healthy uptick—up 6.6% in the last 30 days, 8% year-to-date, and a staggering 73.8% over five years. That kind of financial strength gives McDonald’s room to experiment, but also raises the bar for success.
Why the sudden focus on protein? It’s not a fad, but rather a practical response to medical advice. Doctors often recommend that GLP-1 users eat more protein to help prevent the loss of lean muscle mass. That’s why McDonald’s is considering everything from grilled chicken strips to alternative sandwich bases like cauliflower tortillas, and even smaller burgers wrapped in lettuce—a move already seen at other chains like Shake Shack. Nutritionist Amy Goodson, based in the Dallas-Fort Worth area, suggested such tweaks could make fast food more compatible with these new eating patterns.
But there’s a catch: these changes threaten the traditional pillars of fast food profitability. Sugary drinks, impulse snacks, and desserts have long driven margins and volume at McDonald’s. If GLP-1 users start skipping the soda or dessert, the company will need to respond with alternatives that don’t feel like a punishment—or worse, a loss. Instead, the goal is to offer options that match the customer’s new decision-making logic without losing the magic of fast food: speed, consistency, and a sense of indulgence.
Industry experts, like former McDonald’s US head Mike Haracz, believe the public will soon notice “less carbohydrates and more protein,” with fat potentially becoming a marketing highlight for satiety. The logic is simple: protein and fat are perceived as more filling than sugar and flour-based items. McDonald’s may not need to invent entirely new products; instead, it might just reorganize combos, highlight existing protein-rich items, and tweak how the app suggests add-ons. The consumer, after all, isn’t disappearing—they’re just changing the route to the checkout.
From an investor’s perspective, these menu shifts come at a pivotal moment. McDonald’s is balancing its push into high-protein items, portion control, and beverage and chicken expansion from a position of financial strength. The company is already reporting higher revenue and earnings, so it can afford to test new formats without betting the farm. However, there are risks. If GLP-1 driven calorie reductions cause customers to eat less or visit less frequently, smaller portions and new protein options might not be enough to keep high-income, health-focused diners engaged. There’s also the risk that expanding the menu could strain operations at the franchise level, especially as complexity increases.
Still, the company sees opportunity in beverages—especially its McCafé line—which targets a massive global category and could help McDonald’s compete more directly with coffee and drink-led peers like Starbucks. The chain is also betting that chicken, a versatile and popular protein, can drive repeat visits and create new meal occasions.
The big questions now are: How quickly will high-protein and portion-controlled items roll out? Will customers embrace expanded beverage and chicken lines? And, crucially, will franchisees adapt smoothly to the new menu and equipment demands? As Simply Wall St points out, the ability to keep value-focused customers while attracting more health-conscious and higher-income diners will be central to the success of McDonald’s evolving menu strategy over the next few years.
For now, McDonald’s is taking a measured approach. The company is observing consumer behavior, running tests, and repositioning existing items before launching anything radically new. This strategy allows it to adapt to the “new normal” without abandoning its broad base of customers. The most visible changes might not be in the food itself, but in how options are suggested, grouped, and communicated—helping customers make more intentional, less impulsive choices.
It’s a delicate balancing act: catering to a growing segment of GLP-1 users while preserving the brand’s universal appeal. The outcome could set the tone for the entire fast food industry, as rivals watch closely to see whether McDonald’s can turn a health trend into a competitive advantage—or whether this is merely a course correction for a specific, influential audience.
As McDonald’s tests the waters, one thing is clear: the future of fast food may be less about supersizing and more about satisfying a new kind of hunger—one shaped by science, health, and a changing world.